{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:27:54Z","timestamp":1791959274935,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA78527"],"award-info":[{"award-number":["CA78527"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007320","name":"Albert Einstein Cancer Center","doi-asserted-by":"publisher","award":["P30CA013330"],"award-info":[{"award-number":["P30CA013330"]}],"id":[{"id":"10.13039\/100007320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI-51519"],"award-info":[{"award-number":["AI-51519"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ygyno.2015.05.001","type":"journal-article","created":{"date-parts":[[2015,5,20]],"date-time":"2015-05-20T19:34:48Z","timestamp":1432150488000},"page":"94-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study"],"prefix":"10.1016","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4968-1495","authenticated-orcid":false,"given":"Marina","family":"Frimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"McAndrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana","family":"Harari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zigui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Mirabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Burk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.05.001_bb0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl. 5","key":"10.1016\/j.ygyno.2015.05.001_bb0010","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2015.05.001_bb0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0020","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.05.001_bb0025","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication","volume":"128","author":"Li","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.05.001_bb0030","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.05.001_bb0035","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1158\/1055-9965.EPI-12-1406","article-title":"Human papillomavirus infection and the multistage carcinogenesis of cervical cancer","volume":"22","author":"Schiffman","year":"2013","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0040","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0050","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMcp1210379","article-title":"Clinical practice. Cervical-cancer screening with human papillomavirus and cytologic cotesting","volume":"369","author":"Schiffman","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091905","article-title":"A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive women","volume":"9","author":"Hansel","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ygyno.2015.05.001_bb0060","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.05.001_bb0065","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/djq562","article-title":"Human papillomavirus testing in the prevention of cervical cancer","volume":"103","author":"Schiffman","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/rmv.488","article-title":"Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity","volume":"16","author":"Hebner","year":"2006","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0075","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1158\/1055-9965.EPI-12-0905","article-title":"Human papillomavirus DNA methylation as a potential biomarker for cervical cancer","volume":"21","author":"Clarke","year":"2012","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0080","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","article-title":"A decade of exploring the cancer epigenome \u2014 biological and translational implications","volume":"11","author":"Baylin","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ygyno.2015.05.001_bb0085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nsmb.2518","article-title":"DNA methylation dynamics in health and disease","volume":"20","author":"Bergman","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ygyno.2011.01.013","article-title":"Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer","volume":"121","author":"Sun","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0095","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1101\/gr.083550.108","article-title":"The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer","volume":"19","author":"Fernandez","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0100","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/jnci\/djs135","article-title":"Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population","volume":"104","author":"Mirabello","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.virol.2013.10.032","article-title":"Methylation of human papillomavirus 16, 18, 31, and 45L2 and L1 genes and the cellular DAPK gene: considerations for use as biomarkers of the progression of cervical neoplasia","volume":"448C","author":"Kalantari","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.ygyno.2015.05.001_bb0110","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ijc.28050","article-title":"HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology","volume":"133","author":"Lorincz","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.05.001_bb0115","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/ijc.27750","article-title":"Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia","volume":"132","author":"Mirabello","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.05.001_bb0120","doi-asserted-by":"crossref","first-page":"E146","DOI":"10.1002\/ijc.29119","article-title":"HPV16 methyl-haplotypes determined by a novel next-generation sequencing method are associated with cervical precancer","volume":"136","author":"Mirabello","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.05.001_bb0125","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fgene.2014.00150","article-title":"Characterization of HPV DNA methylation of contiguous CpG sites by bisulfite treatment and massively parallel sequencing\u2014the FRAGMENT approach","volume":"5","author":"Sun","year":"2014","journal-title":"Front. Genet."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.virol.2009.03.029","article-title":"Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy","volume":"389","author":"Brandsma","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.ygyno.2015.05.001_bb0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1590\/S1020-49892004000200002","article-title":"Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica","volume":"15","author":"Bratti","year":"2004","journal-title":"Rev. Panam Salud Publica."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0140","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1086\/428850","article-title":"Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica","volume":"191","author":"Herrero","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0145","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/JCM.00620-08","article-title":"Comparison of two PCR-based human papillomavirus genotyping methods","volume":"46","author":"Castle","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0150","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2183\/pjab.84.321","article-title":"Discovery of bisulfite-mediated cytosine conversion to uracil, the key reaction for DNA methylation analysis\u2014a personal account","volume":"84","author":"Hayatsu","year":"2008","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0155","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/bioinformatics\/18.11.1427","article-title":"MethPrimer: designing primers for methylation PCRs","volume":"18","author":"Li","year":"2002","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ygyno.2015.05.001_bb0160","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/bioinformatics\/btr026","article-title":"Quality control and preprocessing of metagenomic datasets","volume":"27","author":"Schmieder","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ygyno.2015.05.001_bb0165","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/nar\/gkp1137","article-title":"The Sanger FASTQ file format for sequences with quality scores, and the Solexa\/Illumina FASTQ variants","volume":"38","author":"Cock","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nmeth.1184","article-title":"Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex","volume":"5","author":"Hamady","year":"2008","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ygyno.2015.05.001_bb0175","article-title":"The cervical microbiome over 7years and a comparison of methodologies for its characterization","volume":"7","author":"Smith","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ygyno.2015.05.001_bb0180","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/bioinformatics\/btr167","article-title":"Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications","volume":"27","author":"Krueger","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ygyno.2015.05.001_bb0185","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1214\/aos\/1013699998","article-title":"The control of the false discovery rate in multiple testing under dependency","volume":"29","author":"Benjamini","year":"2001","journal-title":"Ann. Stat."},{"key":"10.1016\/j.ygyno.2015.05.001_bb0190","article-title":"R: A Language and Environment for Statistical Computing","author":"RDCT","year":"2011"},{"key":"10.1016\/j.ygyno.2015.05.001_bb0195","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nmeth.1828","article-title":"DNA methylome analysis using short bisulfite sequencing data","volume":"9","author":"Krueger","year":"2012","journal-title":"Nat. Methods"},{"issue":"363","key":"10.1016\/j.ygyno.2015.05.001_bb0200","first-page":"5","article-title":"A sequencing method based on real-time pyrophosphate","volume":"281","author":"Ronaghi","year":"1998","journal-title":"Science"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815008707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815008707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T18:20:28Z","timestamp":1652034028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815008707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0090825815008707"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.05.001","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}